Alphabet Inc., Insider at Verve Therapeutics, Inc. (VERV), sold 145,749 shares at $31.12 ($3.0M) on 2022-11-04, disclosed to the SEC on 2022-11-08.
Scheduled sale ($3.0M) by Insider under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 48,583 | $0 | 0.0% |
| 2 | $31.12 | 47,690 | $1.5M | 49.0% |
| 3 | $31.12 | 47,690 | $1.5M | 49.0% |
| 4 | $31.99 | 650 | $21K | 0.7% |
| 5 | $31.99 | 651 | $21K | 0.7% |
| 6 | $32.90 | 243 |
| $8K |
| 0.3% |
| 7 | $32.90 | 242 | $8K | 0.3% |
| Total | $20.76 avg | 145,749 | $3.0M | 100% |
| Filing → |
| PRME | SELL | 2023-06-20 | $2.2M | — | Filing → |
| PRME | SELL | 2023-05-26 | $728K | — | Filing → |
| PRME | SELL | 2023-05-24 | $3.8M | — | Filing → |